Lundbeck
HLUN-B.CO
#2557
Rank
A$8.63 B
Marketcap
$9.07
Share price
0.05%
Change (1 day)
23.38%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.53

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.57. In 2022 the company made an earnings per share (EPS) of $0.43 a decrease over its 2021 EPS that were of $0.97.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5322.56%
2022$0.43-55.47%
2021$0.97-51.83%
2020$2.02-28.01%
2019$2.81-44.08%
2018$5.0351.94%
2017$3.31126.64%
2016$1.46-120.84%
2015-$7.005622.18%
2014-$0.12-110.03%
2013$1.22-28.08%
2012$1.70-52.1%
2011$3.54-1.31%
2010$3.5915.61%
2009$3.10